Abstract | BACKGROUND: METHODS: Speech tests (communicative suitability, intelligibility, articulation, nasality, and consonant errors) were performed in a control group and in patients before treatment (n = 76), and 6 months (n = 51) and 12 months (n = 42) after treatment. RESULTS: Speech tests were significantly worse for patients before and after treatment compared with the controls. Speech did not improve between 6 and 12 months. After treatment, patients with T3-4 tumors showed a significantly worse score for communicative suitability, intelligibility, and articulation than patients with T2 tumors. No significant differences were found for subsites after treatment, although patients with mobile tongue tumors showed the best results. CONCLUSION: Speech difficulties are significant, and with the knowledge of this study better counseling and vigilance as to speech difficulties may be possible in patients undergoing treatment for oral/ oropharyngeal cancer.
|
Authors | Pepijn A Borggreven, Irma Verdonck-de Leeuw, Johannes A Langendijk, Patricia Doornaert, Marike N Koster, Remco de Bree, C René Leemans |
Journal | Head & neck
(Head Neck)
Vol. 27
Issue 9
Pg. 785-93
(Sep 2005)
ISSN: 1043-3074 [Print] United States |
PMID | 15952194
(Publication Type: Journal Article)
|
Copyright | (c) 2005 Wiley Periodicals, Inc. |
Topics |
- Adult
- Aged
- Analysis of Variance
- Case-Control Studies
- Female
- Humans
- Longitudinal Studies
- Male
- Middle Aged
- Mouth Neoplasms
(pathology, radiotherapy, surgery)
- Oropharyngeal Neoplasms
(pathology, radiotherapy, surgery)
- Postoperative Complications
(physiopathology)
- Radiotherapy, Adjuvant
- Speech Intelligibility
(physiology)
- Speech Production Measurement
- Surgical Flaps
|